We are analyzing https://link.springer.com/article/10.1186/1471-2334-13-22.

Title:
Vitamin D accelerates clinical recovery from tuberculosis: results of the SUCCINCT Study [Supplementary Cholecalciferol in recovery from tuberculosis]. A randomized, placebo-controlled, clinical trial of vitamin D supplementation in patients with pulmonary tuberculosis’ | BMC Infectious Diseases
Description:
Background Vitamin D enhances host protective immune responses to Mycobacterium tuberculosis by suppressing Interferon-gamma (IFN-g) and reducing disease associated inflammation in the host. The objectives of this study were to determine whether vitamin D supplementation to patients with tuberculosis (TB) could influence recovery. Methods Two hundred and fifty nine patients with pulmonary TB were randomized to receive either 600,000 IU of Intramuscular vitamin D3 or placebo for 2 doses. Assessments were performed at 4, 8 and 12 weeks. Early secreted and T cell activated 6 kDa (ESAT6) and Mycobacterium tuberculosis sonicate (MTBs) antigen induced whole blood stimulated IFN-g responses were measured at 0 and 12 weeks. Statistical comparisons between outcome variables at 0 and 12 weeks were performed using Student’s t-test and Chi2 tests. Results After 12 weeks, the vitamin D supplemented arm demonstrated significantly greater mean weight gain (kg) + 3.75, (3.16 – 4.34) versus + 2.61 (95% CI 1.99 – 3.23) p 0.009 and lesser residual disease by chest radiograph; number of zones involved 1.35 v/s 1.82 p 0.004 (95% CI 0.15, 0.79) and 50% or greater reduction in cavity size 106 (89.8%) v/s 111 (94.8%), p 0.035. Vitamin D supplementation led to significant increase in MTBs-induced IFN-g secretion in patients with baseline ‘Deficient’ 25-hydroxyvitamin D serum levels (p 0.021). Conclusions Supplementation with high doses of vitamin D accelerated clinical, radiographic improvement in all TB patients and increased host immune activation in patients with baseline ‘Deficient’ serum vitamin D levels. These results suggest a therapeutic role for vitamin D in the treatment of TB. Trial registration ClinicalTrials.gov; No. NCT01130311; URL: clinicaltrials.gov
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Education
Science
Health & Fitness

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 7,626,432 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We can't see how the site brings in money.

While many websites aim to make money, others are created to share knowledge or showcase creativity. People build websites for various reasons. This could be one of them. Link.springer.com could be secretly minting cash, but we can't detect the process.

Keywords {🔍}

patients, vitamin, hydroxyvitamin, ifng, levels, study, tuberculosis, responses, article, weeks, placebo, arm, pubmed, supplementation, google, scholar, clinical, treatment, figure, data, analysis, disease, therapy, deficient, group, groups, cas, blood, baseline, severity, esat, mtbs, cells, file, pulmonary, sputum, stimulated, chest, serum, score, observed, measured, differences, compared, authors, cell, secretion, cytokine, class, table,

Topics {✒️}

induces ifn-γ-driven monokines induces cathelicidin-mediated killing sputum conversion rates default/dropout rate mycobacterial-antigen induced ifn mycobacterial antigen-induced ifn mycobacterial-antigen stimulated ifn mid-upper arm circumference zahra hasan sputum smear negative intensive-phase antimicrobial treatment pearson chi-squared tests transforming growth factor-beta sputum smear microscopy pre-publication history tuberculosissonicate antigen-induced ifn article download pdf patients post-antituberculous therapy cell activated antigen-6 kda author information authors bone miner res increased mtbs-induced ifn ifn-gamma-producing cells nursing home residents sputum microscopic examinations sputum afb load placebo-controlled clinical trial full size image purified mycobacterial antigens institutional research office privacy choices/manage cookies intervention group post-therapy colorado state university cod liver oil sputum microscopy data dow university hospital recombinant human cytokine aga khan university graphs depict ifn human immunodeficiency virus regular physical activity mycobacterium bovis bcg el-fawal ha tuberculosissonicate induced ifn mycobacterium tuberculosis sonicate authors’ original file holick mf suppressing interferon-gamma supplementation trials failed increased post-therapy

Questions {❓}

Assimon MM, Salenger PV, El-Fawal HA, Mason DL: Nutritional vitamin D supplementation in haemodialysis: A potential vascular benefit?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Vitamin D accelerates clinical recovery from tuberculosis: results of the SUCCINCT Study [Supplementary Cholecalciferol in recovery from tuberculosis]. A randomized, placebo-controlled, clinical trial of vitamin D supplementation in patients with pulmonary tuberculosis’
         description:Vitamin D enhances host protective immune responses to Mycobacterium tuberculosis by suppressing Interferon-gamma (IFN-g) and reducing disease associated inflammation in the host. The objectives of this study were to determine whether vitamin D supplementation to patients with tuberculosis (TB) could influence recovery. Two hundred and fifty nine patients with pulmonary TB were randomized to receive either 600,000 IU of Intramuscular vitamin D3 or placebo for 2 doses. Assessments were performed at 4, 8 and 12 weeks. Early secreted and T cell activated 6 kDa (ESAT6) and Mycobacterium tuberculosis sonicate (MTBs) antigen induced whole blood stimulated IFN-g responses were measured at 0 and 12 weeks. Statistical comparisons between outcome variables at 0 and 12 weeks were performed using Student’s t-test and Chi2 tests. After 12 weeks, the vitamin D supplemented arm demonstrated significantly greater mean weight gain (kg) + 3.75, (3.16 – 4.34) versus + 2.61 (95% CI 1.99 – 3.23) p 0.009 and lesser residual disease by chest radiograph; number of zones involved 1.35 v/s 1.82 p 0.004 (95% CI 0.15, 0.79) and 50% or greater reduction in cavity size 106 (89.8%) v/s 111 (94.8%), p 0.035. Vitamin D supplementation led to significant increase in MTBs-induced IFN-g secretion in patients with baseline ‘Deficient’ 25-hydroxyvitamin D serum levels (p 0.021). Supplementation with high doses of vitamin D accelerated clinical, radiographic improvement in all TB patients and increased host immune activation in patients with baseline ‘Deficient’ serum vitamin D levels. These results suggest a therapeutic role for vitamin D in the treatment of TB. ClinicalTrials.gov; No. NCT01130311; URL: clinicaltrials.gov
         datePublished:2013-01-19T00:00:00Z
         dateModified:2013-01-19T00:00:00Z
         pageStart:1
         pageEnd:11
         license:http://creativecommons.org/licenses/by/2.0
         sameAs:https://doi.org/10.1186/1471-2334-13-22
         keywords:
            Antituberculous Therapy
            Sputum Conversion Rate
            Sputum Smear Conversion
            Mycobacterial Killing
            Tuberculosis Sonicate
            Infectious Diseases
            Parasitology
            Medical Microbiology
            Tropical Medicine
            Internal Medicine
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2334-13-22/MediaObjects/12879_2012_Article_2203_Fig1_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2334-13-22/MediaObjects/12879_2012_Article_2203_Fig2_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2334-13-22/MediaObjects/12879_2012_Article_2203_Fig3_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2334-13-22/MediaObjects/12879_2012_Article_2203_Fig4_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2334-13-22/MediaObjects/12879_2012_Article_2203_Fig5_HTML.jpg
         isPartOf:
            name:BMC Infectious Diseases
            issn:
               1471-2334
            volumeNumber:13
            type:
               Periodical
               PublicationVolume
         publisher:
            name:BioMed Central
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Nawal Salahuddin
               affiliation:
                     name:King Faisal Specialist Hospital & Research Centre
                     address:
                        name:Consultant Department of Adult Critical Care Medicine, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Farheen Ali
               affiliation:
                     name:Aga Khan University
                     address:
                        name:Section of Infectious Disease, Department of Medicine, Aga Khan University, Karachi, Pakistan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Zahra Hasan
               affiliation:
                     name:Aga Khan University
                     address:
                        name:Department of Pathology and Microbiology, Aga Khan University, Karachi, Pakistan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Nisar Rao
               affiliation:
                     name:Ojha Institute of Chest Diseases
                     address:
                        name:Department of Pulmonology, Ojha Institute of Chest Diseases, Karachi, Pakistan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Masooma Aqeel
               affiliation:
                     name:Aga Khan University
                     address:
                        name:Section of Pulmonary and Critical Care Medicine, Department of Medicine, Aga Khan University, Karachi, Pakistan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Faisal Mahmood
               affiliation:
                     name:Aga Khan University
                     address:
                        name:Section of Infectious Disease, Department of Medicine, Aga Khan University, Karachi, Pakistan
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Vitamin D accelerates clinical recovery from tuberculosis: results of the SUCCINCT Study [Supplementary Cholecalciferol in recovery from tuberculosis]. A randomized, placebo-controlled, clinical trial of vitamin D supplementation in patients with pulmonary tuberculosis’
      description:Vitamin D enhances host protective immune responses to Mycobacterium tuberculosis by suppressing Interferon-gamma (IFN-g) and reducing disease associated inflammation in the host. The objectives of this study were to determine whether vitamin D supplementation to patients with tuberculosis (TB) could influence recovery. Two hundred and fifty nine patients with pulmonary TB were randomized to receive either 600,000 IU of Intramuscular vitamin D3 or placebo for 2 doses. Assessments were performed at 4, 8 and 12 weeks. Early secreted and T cell activated 6 kDa (ESAT6) and Mycobacterium tuberculosis sonicate (MTBs) antigen induced whole blood stimulated IFN-g responses were measured at 0 and 12 weeks. Statistical comparisons between outcome variables at 0 and 12 weeks were performed using Student’s t-test and Chi2 tests. After 12 weeks, the vitamin D supplemented arm demonstrated significantly greater mean weight gain (kg) + 3.75, (3.16 – 4.34) versus + 2.61 (95% CI 1.99 – 3.23) p 0.009 and lesser residual disease by chest radiograph; number of zones involved 1.35 v/s 1.82 p 0.004 (95% CI 0.15, 0.79) and 50% or greater reduction in cavity size 106 (89.8%) v/s 111 (94.8%), p 0.035. Vitamin D supplementation led to significant increase in MTBs-induced IFN-g secretion in patients with baseline ‘Deficient’ 25-hydroxyvitamin D serum levels (p 0.021). Supplementation with high doses of vitamin D accelerated clinical, radiographic improvement in all TB patients and increased host immune activation in patients with baseline ‘Deficient’ serum vitamin D levels. These results suggest a therapeutic role for vitamin D in the treatment of TB. ClinicalTrials.gov; No. NCT01130311; URL: clinicaltrials.gov
      datePublished:2013-01-19T00:00:00Z
      dateModified:2013-01-19T00:00:00Z
      pageStart:1
      pageEnd:11
      license:http://creativecommons.org/licenses/by/2.0
      sameAs:https://doi.org/10.1186/1471-2334-13-22
      keywords:
         Antituberculous Therapy
         Sputum Conversion Rate
         Sputum Smear Conversion
         Mycobacterial Killing
         Tuberculosis Sonicate
         Infectious Diseases
         Parasitology
         Medical Microbiology
         Tropical Medicine
         Internal Medicine
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2334-13-22/MediaObjects/12879_2012_Article_2203_Fig1_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2334-13-22/MediaObjects/12879_2012_Article_2203_Fig2_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2334-13-22/MediaObjects/12879_2012_Article_2203_Fig3_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2334-13-22/MediaObjects/12879_2012_Article_2203_Fig4_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2334-13-22/MediaObjects/12879_2012_Article_2203_Fig5_HTML.jpg
      isPartOf:
         name:BMC Infectious Diseases
         issn:
            1471-2334
         volumeNumber:13
         type:
            Periodical
            PublicationVolume
      publisher:
         name:BioMed Central
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Nawal Salahuddin
            affiliation:
                  name:King Faisal Specialist Hospital & Research Centre
                  address:
                     name:Consultant Department of Adult Critical Care Medicine, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Farheen Ali
            affiliation:
                  name:Aga Khan University
                  address:
                     name:Section of Infectious Disease, Department of Medicine, Aga Khan University, Karachi, Pakistan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Zahra Hasan
            affiliation:
                  name:Aga Khan University
                  address:
                     name:Department of Pathology and Microbiology, Aga Khan University, Karachi, Pakistan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Nisar Rao
            affiliation:
                  name:Ojha Institute of Chest Diseases
                  address:
                     name:Department of Pulmonology, Ojha Institute of Chest Diseases, Karachi, Pakistan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Masooma Aqeel
            affiliation:
                  name:Aga Khan University
                  address:
                     name:Section of Pulmonary and Critical Care Medicine, Department of Medicine, Aga Khan University, Karachi, Pakistan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Faisal Mahmood
            affiliation:
                  name:Aga Khan University
                  address:
                     name:Section of Infectious Disease, Department of Medicine, Aga Khan University, Karachi, Pakistan
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:BMC Infectious Diseases
      issn:
         1471-2334
      volumeNumber:13
Organization:
      name:BioMed Central
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:King Faisal Specialist Hospital & Research Centre
      address:
         name:Consultant Department of Adult Critical Care Medicine, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia
         type:PostalAddress
      name:Aga Khan University
      address:
         name:Section of Infectious Disease, Department of Medicine, Aga Khan University, Karachi, Pakistan
         type:PostalAddress
      name:Aga Khan University
      address:
         name:Department of Pathology and Microbiology, Aga Khan University, Karachi, Pakistan
         type:PostalAddress
      name:Ojha Institute of Chest Diseases
      address:
         name:Department of Pulmonology, Ojha Institute of Chest Diseases, Karachi, Pakistan
         type:PostalAddress
      name:Aga Khan University
      address:
         name:Section of Pulmonary and Critical Care Medicine, Department of Medicine, Aga Khan University, Karachi, Pakistan
         type:PostalAddress
      name:Aga Khan University
      address:
         name:Section of Infectious Disease, Department of Medicine, Aga Khan University, Karachi, Pakistan
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Nawal Salahuddin
      affiliation:
            name:King Faisal Specialist Hospital & Research Centre
            address:
               name:Consultant Department of Adult Critical Care Medicine, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Farheen Ali
      affiliation:
            name:Aga Khan University
            address:
               name:Section of Infectious Disease, Department of Medicine, Aga Khan University, Karachi, Pakistan
               type:PostalAddress
            type:Organization
      name:Zahra Hasan
      affiliation:
            name:Aga Khan University
            address:
               name:Department of Pathology and Microbiology, Aga Khan University, Karachi, Pakistan
               type:PostalAddress
            type:Organization
      name:Nisar Rao
      affiliation:
            name:Ojha Institute of Chest Diseases
            address:
               name:Department of Pulmonology, Ojha Institute of Chest Diseases, Karachi, Pakistan
               type:PostalAddress
            type:Organization
      name:Masooma Aqeel
      affiliation:
            name:Aga Khan University
            address:
               name:Section of Pulmonary and Critical Care Medicine, Department of Medicine, Aga Khan University, Karachi, Pakistan
               type:PostalAddress
            type:Organization
      name:Faisal Mahmood
      affiliation:
            name:Aga Khan University
            address:
               name:Section of Infectious Disease, Department of Medicine, Aga Khan University, Karachi, Pakistan
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Consultant Department of Adult Critical Care Medicine, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia
      name:Section of Infectious Disease, Department of Medicine, Aga Khan University, Karachi, Pakistan
      name:Department of Pathology and Microbiology, Aga Khan University, Karachi, Pakistan
      name:Department of Pulmonology, Ojha Institute of Chest Diseases, Karachi, Pakistan
      name:Section of Pulmonary and Critical Care Medicine, Department of Medicine, Aga Khan University, Karachi, Pakistan
      name:Section of Infectious Disease, Department of Medicine, Aga Khan University, Karachi, Pakistan

External Links {🔗}(132)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

5.47s.

LINK . SPRINGER . COM {}